Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedA new revision entry 'Revision: v3.7.0' is added to the study record history, updating the version history. The previous revision 'Revision: v3.6.6' is removed from the current view.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe record history now lists a new revision (v3.6.5) that supersedes the previous version (v3.6.4).SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history now shows a new entry for Revision: v3.6.4, updating the page's revision metadata from v3.6.3.SummaryDifference0.1%

- Check75 days agoChange DetectedThe record history now includes a new version entry for v3.6.3 and removes the previous v3.6.2 entry, signaling an updated revision of the study record. This update documents the latest revision in the history.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the previous revision (v3.6.0) was removed. This reflects an update to the documentation of the page's history.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.